Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination Therapy with Monoamine Oxidase Inhibitors and Other Antidepressants or Stimulants: Strategies for the Management of Treatment‐Resistant Depression
Samantha J. Thomas, Mi-Rae Shin, Melvin G. McInnis, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2015) Vol. 35, Iss. 4, pp. 433-449
Open Access | Times Cited: 100

Showing 51-75 of 100 citing articles:

Alternative splicing in serotonergic system: Implications in neuropsychiatric disorders
Eva Latorre, José Emilio Mesonero, Lorna W. Harries
Journal of Psychopharmacology (2019) Vol. 33, Iss. 11, pp. 1352-1363
Open Access | Times Cited: 11
Spatial working memory performance in children and adolescents with major depressive disorder and dysthymic disorder
Alasdair Vance, Jo Winther
Journal of Affective Disorders (2020) Vol. 278, pp. 470-476
Closed Access | Times Cited: 11
Tranylcypromine: Its Pharmacology, Safety, and Efficacy
Cameron Kiani
American Journal of Psychiatry Residents Journal (2020) Vol. 15, Iss. 4, pp. 3-5
Open Access | Times Cited: 10
Antidepressants in Parkinson's disease. Recommendations by the movement disorder study group of the Neurological Association of Madrid
Esteban Peña, M. Mata, Lydia López Manzanares, et al.
Neurología (English Edition) (2018) Vol. 33, Iss. 6, pp. 395-402
Open Access | Times Cited: 10
SMIP004: A compound with antidepressant-like activities in mouse models
Dan Wang, Xing Xu, Yue Wu, et al.
European Journal of Pharmacology (2018) Vol. 843, pp. 260-267
Closed Access | Times Cited: 9
Role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disorders: a protocol for a systematic review and meta-analysis
Bianca E. Kavanagh, Sharon L. Brennan‐Olsen, Alyna Turner, et al.
BMJ Open (2019) Vol. 9, Iss. 4, pp. e025145-e025145
Open Access | Times Cited: 9
A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice
Javier Pagonabarraga, José Matías Arbelo, Francisco Grandas, et al.
Brain Sciences (2020) Vol. 10, Iss. 3, pp. 176-176
Open Access | Times Cited: 8
Small-molecule control of neurotransmitter sulfonation
Ian Cook, Mary Cacace, Ting Wang, et al.
Journal of Biological Chemistry (2020) Vol. 296, pp. 100094-100094
Open Access | Times Cited: 8
Moclobemide as add-on therapy to agomelatine in a patient with treatment-resistant major depressive disorder: a psychopharmacological case
Matej Štuhec, Róbert Oravecz
Wiener klinische Wochenschrift (2015) Vol. 128, Iss. 7-8, pp. 295-298
Closed Access | Times Cited: 7
Preoperative Management of Medications
Zdravka Zafirova, Karina G. Vázquez-Narváez, Delia Borunda
Anesthesiology Clinics (2018) Vol. 36, Iss. 4, pp. 663-675
Closed Access | Times Cited: 6
Safety and tolerance of combination of monoamine oxidase inhibitors and direct dopamine agonists in adults and older adults with highly resistant depression
Ludovic C. Dormegny-Jeanjean, Olivier Mainberger, Clément de Crespin de Billy, et al.
L Encéphale (2023) Vol. 50, Iss. 2, pp. 137-142
Closed Access | Times Cited: 2
Serum-Derived Exosomes of Patients with Depression with Increased miR-96-5p Inhibit Neuronal Differentiation by Targeting RAC1
Shengwei Wu, Zewei Chen, Zhengzheng Xuan, et al.
Journal of Biomedical Nanotechnology (2023) Vol. 19, Iss. 1, pp. 54-64
Closed Access | Times Cited: 2
Trazodone Addition to Paroxetine and Mirtazapine in a Patient with Treatment-Resistant Depression: The Pros and Cons of Combining Three Antidepressants
Rui Lopes, José Carlos Ribeiro Resende Alves, Raquel Garcia Rego
Case Reports in Medicine (2016) Vol. 2016, pp. 1-6
Open Access | Times Cited: 4
A Rapid Review of “Low-Threshold” Psychiatric Medication Prescribing: Considerations for Street Medicine and Beyond
Blake Erickson, Jarrod Ehrie, Samuel S. Murray, et al.
Psychiatric Services (2022) Vol. 74, Iss. 3, pp. 282-291
Open Access | Times Cited: 4
Synthesis of 2′-(1,2,3-triazoyl)-acetophenones: molecular docking and inhibition ofin vitromonoamine oxidase activity
Gabriel P. Costa, Italo Franco Coelho Dias, Mariana G. Fronza, et al.
New Journal of Chemistry (2020) Vol. 45, Iss. 2, pp. 714-724
Closed Access | Times Cited: 5
Cost variation analysis among different antidepressant drugs used to treat major depressive disorder
Raman Kumar Tripathi, Shamsher Singh
Journal of Pharmaceutical and Biological Sciences (2020) Vol. 6, Iss. 2, pp. 51-54
Open Access | Times Cited: 4
Mechanism of action of antidepressants
Kuldeepak Sharma, Ankush Sundriyal, Aanchal Loshali, et al.
Elsevier eBooks (2022), pp. 255-273
Closed Access | Times Cited: 3
Combination Strategies in Treatment-Resistant Depression
Francisco López‐Muñoz, Cecilio Álamo, Pilar García‐García
Springer eBooks (2016), pp. 421-444
Closed Access | Times Cited: 2
Monoamine Oxidase Inhibitors
Chris Yates, Archit Sharma
Oxford University Press eBooks (2024), pp. 212-213
Closed Access
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive disorders
Д. В. Куркин, Е. И. Морковин, Д. А. Бакулин, et al.
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 5, pp. 22-22
Closed Access
The rapid antidepressant effect of acupuncture on two animal models of depression by increasing the expression of synaptic proteins in the prefrontal cortex
Baile Ning, Zhifang Wang, Qing Yang, et al.
World Journal of Acupuncture - Moxibustion (2024) Vol. 34, Iss. 2, pp. 117-129
Open Access
Core antibiotic resistance genes mediate gut microbiota to intervene in the treatment of major depressive disorder
Zaiquan Dong, Ke Han, Qinglian Xie, et al.
Journal of Affective Disorders (2024) Vol. 363, pp. 507-519
Closed Access
Efficacy and safety of YOXINTINE for depression: a double-blinded, randomized, placebo-controlled, phase 2 clinical trial
Zaiquan Dong, Qi Shen, Hanwen Zhu, et al.
Phytomedicine (2024) Vol. 136, pp. 156204-156204
Closed Access
Mucuna pruriens, a Possible Treatment for Depressive Disorders
Alfonso Mata-Bermúdez, Araceli Dı́az-Ruiz, Luis Ricardo Silva-García, et al.
Neurology International (2024) Vol. 16, Iss. 6, pp. 1509-1527
Open Access
Prevalence and solving strategies of drug-related problems in adult psychiatric inpatients - a systematic review
Katharina Wien, Pamela Reißner, Gudrun Hefner, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access

Scroll to top